AI
VIVO

Analytic Investors’s Meridian Bioscience Inc VIVO Stock Holding History

Analytic Investors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4.21M Sell
218,085
-19,359
-8% -$379K 0.05% 206
2016
Q2 		$4.63M Buy
237,444
+97,247
+69% +$1.91M 0.05% 194
2016
Q1 		$2.89M Buy
140,197
+117,391
+515% +$2.31M 0.04% 255
2015
Q4 		$468K Buy
+22,806
New +$437K 0.01% 508

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Analytic Investors's VIVO Position: Q3 2016 in Review

Analytic Investors reduced its Meridian Bioscience Inc (VIVO) stake by 8.2% in Q3 2016, selling an estimated $379K and leaving 218,085 shares worth $4.21M. The position accounts for 0.05% of the portfolio, ranked #206.

Analytic Investors first reported a position in VIVO in Q4 2015 and has held it in 4 quarters since. The position peaked at $4.63M in Q2 2016. 173 funds tracked by Wall St. Rank hold VIVO as of Q3 2016.

  • Analytic Investors held 218,085 shares of Meridian Bioscience Inc worth $4.21M as of Q3 2016.
  • Analytic Investors sold 19,359 Meridian Bioscience Inc shares in Q3 2016, an estimated $379K.
  • Meridian Bioscience Inc made up 0.05% of Analytic Investors's portfolio in Q3 2016, its #206 holding.
  • Analytic Investors first reported a position in Meridian Bioscience Inc in Q4 2015 and has held it in 4 quarters since.
  • Analytic Investors's Meridian Bioscience Inc position peaked at $4.63M in Q2 2016.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.